These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 37503375)

  • 1. Retracted: Peritumor Edema Serves as an Independent Predictive Factor of Recurrence Patterns and Recurrence-Free Survival for High-Grade Glioma.
    Methods In Medicine CAM
    Comput Math Methods Med; 2023; 2023():9761763. PubMed ID: 37503375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peritumor Edema Serves as an Independent Predictive Factor of Recurrence Patterns and Recurrence-Free Survival for High-Grade Glioma.
    Chen J; Qiu H; Chen R; Huang J; Chen L; Wan J; Chen Q; Zhang L
    Comput Math Methods Med; 2022; 2022():9547166. PubMed ID: 35936378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AQP-4 in peritumoral edematous tissue is correlated with the degree of glioma and with expression of VEGF and HIF-alpha.
    Mou K; Chen M; Mao Q; Wang P; Ni R; Xia X; Liu Y
    J Neurooncol; 2010 Dec; 100(3):375-83. PubMed ID: 20467785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative analysis of permeability for glioma grading using dynamic contrast-enhanced magnetic resonance imaging.
    Zhao M; Guo LL; Huang N; Wu Q; Zhou L; Zhao H; Zhang J; Fu K
    Oncol Lett; 2017 Nov; 14(5):5418-5426. PubMed ID: 29113174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retracted: Multimodal MRI-Based Radiomic Nomogram for the Early Differentiation of Recurrence and Pseudoprogression of High-Grade Glioma.
    International BR
    Biomed Res Int; 2023; 2023():9869137. PubMed ID: 38188730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retracted: Analysis of Clinical Characteristics and Risk Factors of Postoperative Recurrence and Malignant Transformation of Low-Grade Glioma.
    Oncology JO
    J Oncol; 2023; 2023():9832716. PubMed ID: 37476550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retracted: Correlations between Clinical Characteristics and Prognosis in Patients with Grade II Glioma.
    And Alternative Medicine EC
    Evid Based Complement Alternat Med; 2023; 2023():9765049. PubMed ID: 37387973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retracted: Screening and Identification of Key Biomarkers in Lower Grade Glioma via Bioinformatical Analysis.
    And Biomechanics AB
    Appl Bionics Biomech; 2023; 2023():9829723. PubMed ID: 38075158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retracted: Identification and Potential Mechanisms of a 7-MicroRNA Signature That Predicts Prognosis in Patients with Lower-Grade Glioma.
    Healthcare Engineering JO
    J Healthc Eng; 2023; 2023():9807106. PubMed ID: 38094830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of intraoperative B-mode ultrasound and shear wave elastography for glioma grading.
    Yin L; Cheng L; Wang F; Zhu X; Hua Y; He W
    Quant Imaging Med Surg; 2021 Jun; 11(6):2733-2743. PubMed ID: 34079737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retracted: Predictive Value of MRI with Serum Lectin-Reactive Alpha-Fetoprotein for Liver Cancer Recurrence after Percutaneous Radiofrequency Ablation.
    And Alternative Medicine EC
    Evid Based Complement Alternat Med; 2023; 2023():9758092. PubMed ID: 37387929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retracted: Prediction of Cancer-Specific Survival of Brainstem Glioma in Children Based on Risk Stratification Model.
    Methods In Medicine CAM
    Comput Math Methods Med; 2023; 2023():9868734. PubMed ID: 38094386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy evaluation of contrast-enhanced magnetic resonance imaging in differentiating glioma from metastatic tumor of the brain and exploration of its association with patients' neurological function.
    Shi Z; Jiang J; Xie L; Zhao X
    Front Behav Neurosci; 2022; 16():957795. PubMed ID: 36147544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retracted: Recurrence of Early Hepatocellular Carcinoma after Surgery May Be Related to Intestinal Oxidative Stress and the Development of a Predictive Model.
    Longevity OMAC
    Oxid Med Cell Longev; 2023; 2023():9790735. PubMed ID: 37810565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A feline model for experimental studies of peritumor brain edema.
    Bayens-Simmonds J; Boisvert DP; Castro ME; Johnson ES
    J Neurooncol; 1988 Dec; 6(4):371-8. PubMed ID: 3221263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retracted: Predictive Value of Preoperative Dynamic Contrast-Enhanced MRI Imaging Features in Breast Cancer Patients with Postoperative Recurrence Time.
    International EM
    Emerg Med Int; 2024; 2024():9870248. PubMed ID: 38298955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentiating high-grade glioma recurrence from pseudoprogression: Comparing diffusion kurtosis imaging and diffusion tensor imaging.
    Wu XF; Liang X; Wang XC; Qin JB; Zhang L; Tan Y; Zhang H
    Eur J Radiol; 2021 Feb; 135():109445. PubMed ID: 33341429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RETRACTED: Downregulation of miR-204 expression correlates with poor clinical outcome of glioma patients.
    Ye ZN; Liu JP; Wu LY; Zhang XS; Zhuang Z; Chen Q; Lu Y; Liu CG; Zhang ZH; Zhang HS; Hou WZ; Hang CH
    Hum Pathol; 2017 May; 63():46-52. PubMed ID: 28232157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retracted: The Higher Expression of CDCA2 Associated with Poor Prognosis in Glioma.
    Markers D
    Dis Markers; 2023; 2023():9781753. PubMed ID: 37502593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retracted: Application of Deep Learning Technology in Glioma.
    Engineering JOH
    J Healthc Eng; 2022; 2022():9764617. PubMed ID: 36619245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.